Literature DB >> 9815576

Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.

B Uchiyama1, Y Saijo, N Kumano, T Abe, S Fujimura, K Ohkuda, M Handa, K Satoh, T Nukiwa.   

Abstract

The function of proliferation-associated nucleolar protein p120 is unclear. A recent report that a yeast protein, NOP2, 67% homologous to human p120, is up-regulated during the onset of growth and influences the morphology of the nucleolus supports the notion that this protein could serve as a marker for proliferation in neoplastic cells. Lung cancer is characteristic in that different histological types show different biological features. We attempted to evaluate the levels of p120 expression in resected human lung cancer tissues of different histological types and the relation of p120 expression and cell proliferation using human lung cancer cell lines. When 37 frozen specimens of human lung cancer and normal lung were stained with a p120 monoclonal antibody, the nucleoli of cancer cells were positively stained, whereas a few macrophages in normal lung revealed only weak staining. The labeling index of p120 in squamous cell carcinoma (67.7 +/- 12.4%) was significantly higher than that in adenocarcinoma (35.3 +/- 12.6%) or in large cell carcinoma (30.1 +/- 17.3%; P < 0.01). In six human lung cancer cell lines and one normal lung fibroblast cell line cultured in vitro, there was a significant correlation between S-phase fraction and p120 mRNA (r = 0.851, P < 0.02)/p120 protein (r = 0.869, P < 0.01) or between doubling time and p120 protein (r = -0.928, P < 0.01). In the context of the reports that indicate higher [3H]thymidine incorporation and shorter doubling time in the squamous cell carcinoma, these results indicate that p120 can be a marker for proliferation in human lung cancer cells in vivo and in vitro, and that it has an important function in the cell cycle of tumor proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9815576

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

1.  Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.

Authors:  W Hilbe; S Dirnhofer; F Oberwasserlechner; W Eisterer; K Ammann; T Schmid; G Hilbe; J Thaler; E Wöll
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

2.  Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120.

Authors:  Gabrielle Bourgeois; Michel Ney; Imre Gaspar; Christelle Aigueperse; Matthias Schaefer; Stefanie Kellner; Mark Helm; Yuri Motorin
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 3.  The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark.

Authors:  Lukas Trixl; Alexandra Lusser
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-10-11       Impact factor: 9.957

Review 4.  The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer.

Authors:  Anitha Chellamuthu; Steven G Gray
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

5.  Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma.

Authors:  Hanrong Li; Huiming Jiang; Zhicheng Huang; Zhilin Chen; Nanhui Chen
Journal:  Cancer Manag Res       Date:  2021-08-24       Impact factor: 3.989

6.  Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs.

Authors:  Han Liao; Anushri Gaur; Hunter McConie; Amirtha Shekar; Karen Wang; Jeffrey T Chang; Ghislain Breton; Catherine Denicourt
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

7.  M5C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinoma.

Authors:  Hui Chen; Xiao-Lin Ge; Zhao-Yue Zhang; Ming Liu; Rui-Yan Wu; Xiao-Fei Zhang; Li-Ping Xu; Hong-Yan Cheng; Xin-Chen Sun; Hong-Cheng Zhu
Journal:  Transl Lung Cancer Res       Date:  2021-05

Review 8.  Disruption of the RNA modifications that target the ribosome translation machinery in human cancer.

Authors:  Maxime Janin; Laia Coll-SanMartin; Manel Esteller
Journal:  Mol Cancer       Date:  2020-04-02       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.